&nbsp;

deaths-avoided.png

Sep 2024

Regimen

PEMB

Cancer Type:

Skin,

Melanoma

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Pembrolizumab - (Neo)adjuvant Treatment for Completely Resectable Stage III or IV Melanoma

Drugs Used:

pembrolizumab

Quick Link(s):

Regimen Monograph

Oct 2024

Regimen

PEME+OSIM(MNT)

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

pemetrexed,

osimertinib (Unfunded)

Quick Link(s):

Regimen Monograph

Oct 2024

Regimen

DANAFARBER(INT-CALA)

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative

Funding:

ODB - General Benefit

mercaptopurine

ODB - General Benefit

dexamethasone

New Drug Funding Program

Calaspargase Pegol (Outpatient) - Newly Diagnosed Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed_Biphenotypic Leukemia

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2024

Document

Postcard.zip

Nov 2024

Document

Poster.zip

Nov 2024

Regimen

POMP

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative

Funding:

ODB - General Benefit

mercaptopurine

ODB - General Benefit

prednisone

ODB - General Benefit

methotrexate - oral tablets

New Drug Funding Program

Pegaspargase (Outpatient) - Adult Acute Lymphoblastic Leukemia (ALL) Lymphoblastic Lymphoma Mixed or Biphenotypic Leukemia

New Drug Funding Program

Calaspargase Pegol (Outpatient) - Newly Diagnosed Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed_Biphenotypic Leukemia

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2024

Regimen

PEMB+TRAS(MNT)

Cancer Type:

Gastrointestinal,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab and Trastuzumab (Biosimilar) - First-line Treatment of Advanced HER2-Positive Gastric or Esophagogastric Junction Adenocarcinoma

New Drug Funding Program

Pembrolizumab and Trastuzumab (Biosimilar) - First-line Treatment of Advanced HER2-Positive Gastric or Esophagogastric Junction Adenocarcinoma

Drugs Used:

pembrolizumab,

trastuzumab

Quick Link(s):

Regimen Monograph

Dec 2024

Regimen

PEMB(MNT)

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer

Drugs Used:

pembrolizumab

Quick Link(s):

Regimen Monograph

Dec 2024

Data Book – Information & Reporting Standards

Document

Declined-Referral-Letter-Template-EN.docx

Dec 2024

Document